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ABSTRACT
The objective of this study was to assess the effect of 
treating cows with teat sealant only compared with an-
tibiotic plus teat sealant at drying off on weekly somatic 
cell count, potential intramammary infection, and milk 
production across the entire subsequent lactation. In 3 
research herds in the south of Ireland, cows with SCC 
that did not exceed 200,000 cells/mL in the previous 
lactation (LowSCC) were randomly assigned to 1 of 
2 treatments at drying off: internal teat sealant alone 
(ITS) or antibiotic plus teat sealant (AB+ITS). Cows 
with SCC that exceeded 200,000 cells/mL in the previ-
ous lactation were treated with AB+ITS and included 
in the analyses as a separate group (HighSCC). Weekly 
individual animal composite SCC records were available 
for 654 cow lactations and were transformed to somatic 
cell scores (SCS) for the purpose of analysis. Data were 
divided into 3 data sets to represent records obtained 
(1) up to 35 DIM, (2) up to 120 DIM, and (3) across the 
lactation. Foremilk secretions were taken from all quar-
ters at drying off, at calving, 2 wk after calving, and in 
mid-lactation and were cultured to detect the presence 
of bacteria. The LowSCC cows treated with ITS alone 
had higher daily milk yield (0.67 kg/d) across lactation 
compared with LowSCC cows treated with AB+ITS. 
The LowSCC cows treated with ITS alone had higher 
SCS in early, up to mid, and across lactation compared 
with LowSCC cows treated with AB+ITS. We detected 
no difference in weekly SCS of LowSCC cows treated 
with ITS alone and SCS of HighSCC cows. The least 
squares means back-transformed SCC across lactation 
of the LowSCC cows treated with ITS alone, LowSCC 
cows treated with AB+ITS, and HighSCC cows were 
41,523, 34,001, and 38,939 cells/mL respectively. The 
odds of LowSCC cows treated with ITS alone having 
bacteria present in their foremilk across lactation was 
2.7 (95% confidence interval: 1.91 to 3.85) and 1.6 (1.22 
to 2.03) times the odds of LowSCC cows treated with 
AB+ITS and of HighSCC cows treated with AB+ITS, 
respectively. In this study, Staphylococcus aureus was 
the most prevalent pathogen isolated from the popula-
tion. Recategorizing the threshold for LowSCC cows 
as ≤150,000 cells/mL or ≤100,000 cells/mL in the 
previous lactation had no effect on the results. The 
results indicate that herds with good mastitis control 
programs may use ITS alone at dry-off in cows with 
SCC <200,000 cells/mL across lactation with only a 
small effect on herd SCC.
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INTRODUCTION
Mastitis is the predominant reason for antibiotic use 
in the dairy industry (Heringstad et al., 2000). Public 
concern over the use of antibiotics is rising, especially 
as it relates to antibiotic usage in agriculture and the 
implications for antimicrobial resistance (Prestinaci et 
al., 2015). In response, scientists and veterinary orga-
nizations have questioned the use of dry-cow antibiot-
ics in cows with low SCC or in cows with no IMI at 
drying off (Cameron et al., 2014). A recent analysis 
of antibiotic use at dry-off across 1,657 Austrian dairy 
farms showed that only 31.3% of cows on those farms 
were dried off using antibiotics (Wittek et al., 2018). In 
Ireland, however, dry-cow antibiotic therapy remains 
a standard part of mastitis control and is used on al-
most 100% of cows (More et al., 2017). It is used both 
therapeutically (to treat infections present at the end of 
lactation) and prophylactically (to prevent new infec-
tions during the dry period). However, dry-cow therapy 
is only one critical component of mastitis control.
During the dry period, a keratin plug forms in the 
teat canal (Paulrud, 2005) and acts as a natural defense 
mechanism to protect against microbial infections. 
However, this natural protective mechanism is not al-
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ways effective. Internal teat sealants that mimic the 
natural keratin plug can be infused into the teat canal 
at drying-off (Meaney, 1977). Cameron et al. (2014) 
showed no difference in the likelihood of contracting an 
IMI during the dry period when cows were selectively 
treated with either antibiotic plus teat sealant or in-
ternal teat sealant alone. Bradley et al. (2010) showed 
no difference in the likelihood of contracting mastitis 
between ipsilateral quarters treated with internal teat 
sealant and antibiotic and those treated with teat 
sealant alone. However, the effects of treatment with 
antibiotic plus teat sealant versus teat sealant alone 
on subsequent mid- to late-lactation mastitis and SCC 
have not been studied; some studies investigated the ef-
fects of treatment up to 100 DIM (Bradley et al., 2010) 
or to 120 DIM (Cameron et al., 2014). Rabiee and Lean 
(2013) undertook a meta-analysis of the effect of teat 
sealant products on IMI, mastitis, and SCC and con-
cluded that further studies on the impact of the use of 
teat sealants alone on SCC are required. The objective 
of this study was to quantify the effect of administra-
tion of an internal teat sealant alone compared with 
treatment with antibiotic plus teat sealant at drying 
off on subsequent SCC, potential infection, and milk 
production across the entire subsequent lactation in 
spring-calving, grazing dairy cows.
MATERIALS AND METHODS
This study was approved by the Teagasc Animal 
Ethics Committee and all procedures were authorized 
and carried out in accordance with the Health Products 
Regulatory Authority (HPRA) of Ireland.
Data
Multiparous cows from 3 research herds operated by 
the Teagasc Animal and Grassland Research and In-
novation Center and located in Co. Cork, Ireland, were 
enrolled in the study. The study was undertaken in the 
Teagasc Clonakilty research herd from 2015 to 2017, 
and in the Teagasc Moorepark and Teagasc Curtins 
research herds in 2017. These herds were chosen for 
this study because of their historically low bulk tank 
SCC; herd SCC remained below 200,000 cells/mL for 
the majority of the year before the trial. Bulk tank 
SCC exceeded 200,000 cells/mL only in January (n = 
2) and February (n = 2), coinciding with the onset of 
calving in the research herds. Throughout the period of 
the present study, all cows were on concurrent studies 
investigating the effects of alternative grass-based diets 
on animal performance. All animals were spring calving 
(i.e., calved between mid-January and April, inclusive) 
and were housed over the dry period in group housing 
that had individual cubicles available for all cows as 
well as automatic scrapers. Cubicles were cleaned and 
lined daily. Only cows that were dried-off between No-
vember and December before calving were considered 
for this study.
Throughout lactation, individual animal daily milk 
yield and milk fat and protein composition were record-
ed, once weekly, using consecutive evening and morn-
ing milk samples; individual animal SCC was recorded 
once weekly on the morning milk sample using a Foss 
FT 6000 Milkoscan and Fossomatic FC (Foss, Hillerød, 
Denmark).
Treatment Administration
Eligibility for inclusion in the experiment was deter-
mined 4 to 6 wk before drying-off. Cows were deemed 
eligible if SCC had not exceeded 200,000 cells/mL at 
any time during the previous lactation and they had 
not presented with a clinical case of mastitis during the 
previous lactation (LowSCC). Eligible LowSCC cows 
were blocked according to expected calving date, ex-
perimental treatment (on the concurrent experiment), 
and parity number. Within block, LowSCC cows were 
randomly administered 1 of 2 treatments: internal 
teat sealant (Boviseal, Bimeda, Dublin, Ireland; www 
.bimeda .ie) alone (ITS) or a cephalonium-based anti-
biotic treatment (Cepravin Dry Cow Intramammary 
Suspension, MSD Animal Health, Kenilworth, NJ; 
www .msd -animal -health .co .in) followed by internal teat 
sealant (AB+ITS). Cows that had a SCC >200,000 
cells/mL or presented a case of clinical mastitis in the 
previous lactation were administered AB+ITS and in-
cluded in all analyses as a separate group (HighSCC).
Before treatment administration, strict teat disinfec-
tion procedures were implemented. The teat end and 
orifice were scrubbed with cotton wool soaked in meth-
ylated spirits until no trace of dirt could be identified on 
the cotton wool. Antibiotic therapy was administered 
to selected (AB+ITS and HighSCC) cows by gently 
inserting the nozzle of the treatment partially into the 
teat canal; the contents were infused and the teat was 
massaged. Teat sealant was administered to all animals 
similarly (following administration of antibiotic treat-
ment in cows that were receiving both treatments); 
however, the teat was not massaged and the base of the 
teat was held throughout treatment administration. All 
teats were sprayed immediately after treatment with 
commercial teat spray, and treated animals were sub-
sequently left to stand for 15 min before returning to 
cubicles.
The entire data set included 131, 128, and 395 cows 
that calved in 2015, 2016, and 2017, respectively, of 
which 67, 69, and 177, were LowSCC, respectively.
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Quarter-Level Sampling
Individual quarter secretions of cows were taken in 
an aseptic manner on 4 occasions: (1) at dry-off after 
enrollment, (2) at first milking post-calving, (3) 14 d 
after calving, and (4) in mid lactation (approximately 
120 DIM). Samples were obtained by trained person-
nel. Before sample collection, each teat was washed and 
dried where necessary and scrubbed with a cotton swab 
soaked in methylated spirits; quarters were cleaned 
from front to rear. The first 3 squirts of milk were dis-
carded to remove contaminated milk and material from 
the tip of the teat. Samples were subsequently collected 
from rear to front into sterile capped 30-mL tubes color 
coded to represent each quarter. Samples were refriger-
ated and analyzed within 24 h of collection.
All foremilk secretions had SCC quantified and were 
cultured for the presence of bacteria. The SCC of the 
first postcalving milk sample was estimated by trained 
personnel using the California Mastitis Test (CMT; 
Ferronatto et al., 2018) because of the viscosity of the 
colostrum. The CMT is a subjective test of SCC us-
ing results of negative, trace, weak positive, distinct 
positive, and strong positive (Schalm and Noorlander, 
1956), which were numbered 1 (negative) to 5 (strong 
positive) for the purposes of this study. The SCC of 
all other quarter-level secretions were quantified using 
a Bentley Somacount 300, which uses a proprietary 
method of laser-based flow cytometry to quantify so-
matic cells (Bentley Instrument Inc., Chaska, MN).
Foremilk samples were cultured to isolate and identify 
bacteria using blood agar plates. The blood agar plate 
was divided into 4 equal sections and clearly identi-
fied with cow identification and quarter. Samples were 
plated using 10-μL aseptic loops, incubated at 37°C, 
and examined after 18 to 24 h for growth morphologic 
features such as colony size, shape, color, and hemolytic 
characteristics. Any bacterial growth on the blood agar 
plates was considered to indicate the presence of bacte-
ria. Samples with more than 2 bacterial species present 
were considered contaminated samples and discarded 
from analyses.
Data Analysis
Somatic cell count was transformed to SCS by tak-
ing the logarithm to the base 10 of SCC (after adding 
a shift parameter of 1). Parities >3 were grouped to-
gether for analysis. Cow breed composition as obtained 
from the national database (http: / / www .icbf .com) was 
redefined for the present study as the proportion of 
Holstein-Friesian, Jersey, Norwegian Red, and “other.” 
Coefficients of heterosis and recombination loss were 
calculated for each cow according to VanRaden and 
Sanders (2003).
Data Sets. Individual animal SCS data were avail-
able for each week of lactation; 3 data sets were gener-
ated: (1) the first 3 records of SCS taken within the 
first 35 DIM were retained for analysis; (2) the first 
120 d of lactation wherein weekly records (n = 12–15) 
of SCS up to 120 DIM were retained for analysis; and 
(3) the complete lactation wherein all SCS records (n = 
26–38) up to dry-off were included in analysis.
Bacteriology results of quarter foremilk secretions 
taken at dry-off were not available for cow treatment 
allocation. To account for potential bias in the level of 
potential IMI at dry-off in different treatment groups, 
a separate data set was generated (NoIMI) for each 
series of analyses, in which cows that had bacteria 
present in their foremilk at the time of treatment al-
location were subsequently removed from the analyses; 
11.5 and 10.2% of cow lactations were removed from 
the LowSCC ITS and AB+ITS data sets, respectively.
To assess the impact of our selection criteria on the 
results, 2 additional series of analyses were tested. Ani-
mal eligibility for classification as LowSCC was reas-
signed on the basis that SCC had not exceeded 150,000 
cells/mL and, in a separate series of analyses, had not 
exceeded 100,000 cells/mL in the previous lactation. 
Cows that exceeded these thresholds were moved to the 
HighSCC treatment group for their respective analyses.
SCC Variables. In addition to test-day SCS, the 
mean, minimum, and maximum SCS were quantified 
separately within cow-lactation for each analyzed peri-
od (i.e., first 3 records, first 120 d, and all of lactation). 
Furthermore, we quantified the number of records with 
SCC >200,000 cells/mL within a cow-lactation for each 
studied period.
The effect of treatment (ITS, AB+ITS, or HighSCC) 
on mean, minimum, and maximum SCS was quanti-
fied using a repeatability linear mixed model in SAS 
(SAS Institute, 2017) and adjusted for the fixed effects 
of experimental treatment (of the concurrent trial), 
coefficients of heterosis and recombination, month of 
calving (January, February, March, April), parity (2, 
3, 4+), and year (2015, 2016, 2017). The proportion 
of Holstein-Friesian, Jersey, and Norwegian Red were 
fitted as separate continuous variables; the “other” 
breed was not included to avoid linear dependency in 
the model. Initial analyses indicated a difference in 
milk yield across treatment groups; thus, average daily 
milk yield from the previous lactation was included as 
a continuous effect. Cow across year was included as 
a repeated effect. Model covariance structure was se-
lected using Akaike’s information criterion to compare 
the log-likelihood of alternative models with identical 
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fixed effects. An autoregressive covariance structure 
with heterogeneous variance was fitted. Test-day SCS 
was analyzed using a similar model to the summary 
SCS traits, with cow included as a random effect and 
week of lactation as a repeated effect nested within cow-
lactation; an autoregressive covariance structure with 
compound symmetry was fitted. The effect of treat-
ment on daily milk yield and weekly milk composition 
was quantified using the same model as test-day SCS, 
with the inclusion of days in milk as an explanatory 
variable when milk yield was the dependent variable 
and the inclusion of test-day SCS as an explanatory 
variable when either milk yield or composition were 
dependent variables. The effect of treatment on the 
number of records with high SCC (>200,000 cells/mL) 
was quantified using an ordinal regression model with 
a cumulative logit link function (Proc Genmod; SAS 
Institute, 2017) adjusted for the same fixed effects as 
the linear model to quantify summary SCS traits, with 
cow included as a repeated effect.
Individual Quarter SCC. The effect of treatment 
on quarter level SCS was analyzed by (1) considering 
each time point independently, and (2) considering 
samples taken at 2 wk postcalving and at mid-lactation 
jointly. All models were adjusted for the fixed effects 
of experimental treatment (of the concurrent trial); 
proportion of Holstein-Friesian, Jersey, and Norwegian 
Red; coefficients of heterosis and recombination; month 
of calving (January, February, March, April); parity 
(2, 3, 4+); year (2015, 2016, 2017); and quarter (right 
front, right hind, left front, and left hind). Quarter 
samples that had SCC quantified using CMT were 
analyzed using ordinal regression with a cumulative 
logit link function (Proc Genmod, SAS Institute, 2017) 
and included the repeated effect of quarter nested with 
cow lactation. Samples taken at 2 wk postcalving and 
mid lactation were analyzed using a repeatability linear 
mixed model in SAS (SAS Institute, 2017) and included 
the repeated effect of quarter nested within cow lacta-
tion. When all time points were analyzed together, a 
repeatability model that included quarter treated as a 
repeated effect nested within time of sampling and cow 
lactation was tested.
Presence of Bacteria. Presence of bacteria was 
dichotomized as present or absent and analyzed us-
ing a logistic regression model (Proc Genmod; SAS 
Institute, 2017) adjusted for the same fixed effects as 
for the CMT analyses. Because of the smaller data 
set available for the bacteriology analyses, concurrent 
experimental treatment was replaced by experimental 
farm as an explanatory variable. Quarter was treated 
as a repeated effect nested within cow, year, and time 
of sampling.
RESULTS
The number of cow lactations and records included 
in each treatment group for analysis and their daily 
milk yield and fat and protein composition are shown 
in Table 1. The strict data-editing criteria used resulted 
in different treatment group sizes available for analyses; 
data were required to be recorded within 35 DIM (for 
inclusion in the “first 3 records” data set), and a mini-
mum of 12 and 26 records per lactation were required 
for inclusion in the “first 120 DIM” and “full lactation” 
data sets, respectively. Of the 83 cows present in the 
herd for the 3 yr of the study (only one herd partici-
pated for the entire study), 17 cows were classified as 
LowSCC across all 3 yr, whereas 13 cows were never 
classified as LowSCC.
Table 1. Number of cows, lactations, and records and least squares means (SE in parentheses) daily milk yield (kg) and weekly milk fat and 
protein percent within the first 3 records (early), up to 120 DIM (mid) and across lactation (full)1
Period and  
treatment Cows (no.)
Lactations  
(no.)
Records  
(no.) Milk (kg) Fat (%) Protein (%)
Early       
 ITS 141 160 366 22.28 (0.49)A 5.12 (0.08)A 3.61 (0.03)A
 AB+ITS 137 160 371 22.06 (0.48)A 5.02 (0.08)A 3.59 (0.03)A
 HighSCC 284 342 793 21.84 (0.44)A 5.08 (0.07)A 3.59 (0.03)A
Mid       
 ITS 145 163 2,377 23.69 (0.31)A 4.60 (0.03)A 3.55 (0.01)A
 AB+ITS 134 156 2,303 23.42 (0.33)A 4.62 (0.03)A 3.56 (0.01)A
 HighSCC 288 341 5,000 23.39 (0.28)A 4.61 (0.03)A 3.55 (0.01)A
Full       
 ITS 142 159 5,348 24.75 (0.22)A 4.84 (0.03)A 3.84 (0.01)A
 AB+ITS 132 154 5,166 24.09 (0.22)B 4.85 (0.03)A 3.85 (0.01)A
 HighSCC 287 341 11,248 24.15 (0.20)B 4.84 (0.02)A 3.83 (0.01)A
A,BMeans with different superscripts within a column and time period differed significantly at P < 0.001.
1LowSCC cows did not exceed 200,000 cells/mL or present with clinical mastitis in the previous lactation; HighSCC cows exceeded 200,000 
cells/mL at least once or presented with clinical mastitis in previous lactation. LowSCC cows were treated with teat sealant alone (ITS) or with 
antibiotic plus teat sealant (AB+ITS); HighSCC cows were treated with AB+ITS.
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Cows administered AB+ITS had 0.67 kg (95% CI: 
0.35 to 0.93kg) lower daily milk yield than cows admin-
istered ITS alone when records from across the lacta-
tion were considered (Table 1). No differences in milk 
composition were observed across treatment groups 
(Table 1).
The percent of quarters identified with bacteria at 
different time points of lactation are presented in Table 
2 for cows in all treatment groups. Staphylococcus au-
reus was the most prevalent pathogen among the popu-
lations included in this study and was identified at each 
time point in each treatment group (Table 2). With 
the exception of Escherichia coli, the listed pathogens 
were present across lactation in at least one treatment 
group.
Composite SCC
LowSCC cows administered AB+ITS at dry-off had 
lower test-day SCS in the first 3 records (P = 0.03), 
the first 120 d (P = 0.003), and across the entire lac-
tation (P = 0.003) relative to cows administered ITS 
alone (Table 3). We detected no difference in test-day 
SCS between HighSCC cows and either of the LowSCC 
treatment groups up to 120 DIM; however, test-day 
SCS was lower in the LowSCC AB+ITS group than 
in the HighSCC group when the entire lactation was 
considered (P = 0.01; Table 3). Mean, minimum, and 
maximum SCS were lower in the AB+ITS group than 
in the ITS group in early lactation (P < 0.05; Table 3). 
However, minimum SCS did not differ between groups 
later in lactation. Mean, minimum, and maximum SCS 
did not differ between cows administered ITS alone and 
HighSCC cows at any time point. Figure 1 shows the 
LSM test-day SCS of LowSCC cows in both the ITS 
and AB+ITS treatment groups for each 50 d of lacta-
tion and indicates that the SCS of cows given ITS alone 
was significantly higher until d 250 of lactation, after 
which no difference was observed between the 2 groups.
The odds of cows administered ITS alone having an 
SCC reading >200,000 cells/mL within the first 3 re-
cords and 120 d of lactation, respectively, was 2.9 (95% 
CI: 1.2 to 7.0) and 3.0 (95% CI: 1.6 to 5.8) times the 
odds of cows administered AB+ITS having an SCC 
reading of >200,000 cells/mL. In total, 19.5 and 9.1% 
of LowSCC cow lactations treated with ITS alone or 
with AB+ITS and 19.1% of HighSCC cow lactations 
had an SCC reading >200,000 cells/mL in the first 35 
DIM; the percentage of records that exceeded 200,000 
cells/mL were 7.5, 2.4, and 9.7% for ITS, AB+ITS, 
and HighSCC groups, respectively. However at the end 
of lactation (>239 d), 29.5, 29.9, and 45.2% of ITS, 
AB+ITS, and HighSCC cow lactations had had an 
SCC reading >200,000 cells/mL (Figure 2). Ta
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The LSM of SCS of all treatment groups was numeri-
cally lower in the NoIMI data set (Table 4) relative to 
the full data set (Table 3); however, the difference in 
mean, minimum, and maximum SCS between treatment 
groups did not change. There was no difference in the 
test-day SCS of LowSCC and HighSCC groups up to 
mid lactation in the full data set (Table 3); however, in 
the NoIMI data set, the test-day SCS of LowSCC cows 
treated with AB+ITS was lower than that of HighSCC 
cows in the first 3 records, whereas the test-day SCS 
of LowSCC cows treated with ITS alone was higher 
than that of either group treated with antibiotics up to 
mid lactation (Table 4). In the NoIMI data set, cows 
administered ITS alone were 3.4 (95% CI: 1.24 to 9.27) 
and 4.4 (95% CI: 2.03 to 9.37) times more likely to have 
an SCC reading >200,000 cells/mL within the first 3 
records and within 120 DIM, respectively, relative to 
LowSCC cows treated with AB+ITS.
The proportion of cows eligible for inclusion in the 
experiment decreased from 48% to 38 and 25% when 
the threshold for inclusion in the LowSCC treatment 
groups decreased from a maximum previous lacta-
tion SCC reading of 200,000 cells/mL to 150,000 and 
100,000 cells/mL, respectively. Regardless of the selec-
tion threshold imposed, LowSCC cows treated with 
ITS had higher SCS than LowSCC cows treated with 
AB+ITS (Table 5).
Quarter-Level SCC and Bacteriology
We found no difference in quarter-level SCS be-
tween quarters of cows treated with ITS alone or with 
AB+ITS. However, both of the LowSCC groups had 
lower quarter-level SCS at 120 DIM compared with 
that of the HighSCC group (P < 0.001).
Across lactation, 6.0% of quarters of LowSCC cows 
treated with ITS, 2.6% of quarters of LowSCC treated 
with AB+ITS, and 5.2% of quarters of HighSCC cows 
had bacteria present in the foremilk. The odds of 
LowSCC cows treated with ITS having bacteria pres-
ent in their foremilk, therefore, was 2.7 (95% CI: 1.91 
to 3.85) and 1.6 (95% CI: 1.22 to 2.03) times the odds 
of LowSCC cows treated with AB+ITS and the odds 
of HighSCC cows treated with AB+ITS, respectively. 
Although cows treated with antibiotic at dry-off (both 
LowSCC and HighSCC cows) had a numerically lower 
incidence of Staphylococcus aureus and nonhemolytic 
staphylococci detected in their foremilk at calving 
relative to at drying-off, LowSCC cows treated with 
ITS only had numerically similar or increased levels of 
those pathogens detected after dry-off (Table 2). No 
difference in the type of bacteria present was detected 
between treatment groups.
DISCUSSION
Blanket dry-cow therapy historically formed part of a 
5-point plan to reduce mastitis; however, the substan-
tial improvements in herd-level SCC observed in recent 
years (Berry et al., 2006) bring into question the cur-
rent requirement for blanket therapy of all herds. Bulk 
tank SCC from the Irish national database showed 
an increase in the proportion of both herds and milk 
volume with an annual average SCC <200,000 cells/
mL from 39 to 62% and from 46 to 67%, respectively, 
between 2013 and 2016 (AHI, 2018). Selective dry-cow 
Table 3. Least squares means (SE in parentheses) of test-day SCS and lactation mean, minimum, and 
maximum SCS within the first 3 records (early), up to 120 DIM (mid), and across lactation (full)1
Period and  
treatment
SCS
Test-day Mean Minimum Maximum
Early     
 ITS 4.64 (0.050)A 4.66 (0.049)A 4.47 (0.045)A 4.83 (0.059)A
 AB+ITS 4.55 (0.051)B 4.56 (0.049)B 4.40 (0.046)B 4.72 (0.059)B
 HighSCC 4.61 (0.045)AB 4.64 (0.044)A 4.46 (0.041)A 4.84 (0.052)A
Mid     
 ITS 4.49 (0.038)A 4.50 (0.038)A 4.05 (0.036)A 5.14 (0.066)A
 AB+ITS 4.38 (0.040)B 4.41 (0.040)B 4.00 (0.038)A 4.95 (0.069)B
 HighSCC 4.45 (0.034)AB 4.47 (0.035)A 4.04 (0.033)A 5.09 (0.059)A
Full     
 ITS 4.62 (0.034)A 4.64 (0.034)A 3.99 (0.034)A 5.42 (0.062)A
 AB+ITS 4.53 (0.035)B 4.56 (0.034)B 3.98 (0.035)A 5.24 (0.064)B
 HighSCC 4.59 (0.031)A 4.61 (0.031)A 3.99 (0.031)A 5.43 (0.055)A
A,BMeans with different superscripts within a column and time period differed significantly at P < 0.05.
1LowSCC cows did not exceed 200,000 cells/mL or present with clinical mastitis in the previous lactation; 
HighSCC cows exceeded 200,000 cells/mL at least once or presented with clinical mastitis in previous lacta-
tion. LowSCC cows were treated with teat sealant alone (ITS) or with antibiotic plus teat sealant (AB+ITS); 
HighSCC cows were treated with AB+ITS.
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therapy is a concept gaining ground in dairy produc-
tion systems worldwide at varying rates. Vanhoudt 
et al. (2018) reported that, in 2015 (over 2 yr after 
the ban on preventative antimicrobials was issued to 
Dutch dairy farmers), a median of 55% of dry periods 
of 20 Dutch commercial herds studied did not have 
antimicrobials administered. However, dry-cow therapy 
coverage is estimated to be much higher in Irish dairy 
herds (More et al., 2017). Therefore, the objective of 
this study was to assess the potential for a selective 
dry-cow therapy program in Irish grazing dairy cows.
Using Teat Sealant Alone to Control SCC
Motivation for this study was drawn from the increas-
ing public concern at the high level of antimicrobial use 
in our livestock industries and the potential to reduce 
the level of prophylactic antimicrobials used. Thus, 
the pertinent question for this study was the efficacy 
of teat sealant alone in place of antibiotic treatment 
plus teat sealant to prevent new infections. Few studies 
have reported this comparison. Bradley et al. (2010) 
administered teat sealant only or teat sealant plus an-
tibiotic in ipsilateral quarters of 433 cows in 6 commer-
cial herds in southwest England. Those authors found 
no difference between treatments in the likelihood of 
contracting mastitis up to 100 DIM. In the study of 
Bradley et al. (2010), the cow was her own control; 
however, quarter interdependency was accounted for 
through random allocation of treatment to either the 
left or right side. More recently, Vasquez et al. (2018) 
showed no difference in the cure rate or new infection 
rate of 611 cows treated with either teat sealant only or 
antibiotic plus teat sealant, although the teat sealant 
group tended to perform worse (P = 0.09). However, 
the study of Vasquez et al. (2018) used a single applica-
tion of an external teat sealant, which is expected to 
offer less protection than a properly inserted internal 
teat sealant (Lim et al., 2007), as was used in the pres-
ent study.
Using teat sealant alone compared with antibiotic 
plus teat sealant resulted in a reduction of the herd 
usage of dry-cow antimicrobials. Potentially 48% fewer 
cow-lactations required antimicrobials at drying-off 
in these research herds than if the traditional blanket 
therapy approach had been adopted (because of the 
randomization of treatment across the LowSCC cows, 
the reduction in lactations treated with dry-off antimi-
crobials was actually 24%). However, cows that did not 
receive prophylactic treatment had a greater probability 
of an SCC exceeding 200,000 cells/mL during lactation. 
More et al. (2017) recently reported an inverse relation-
ship between sales of antimicrobial tubes for lactation 
use and sales of antimicrobial tubes for dry-cow therapy 
over the same period in Ireland. Scherpenzeel et al. 
(2014) used a split-udder design, treating 2 quarters 
Figure 1. Least squares means SCS (±1.96 SE) of cows with historically low SCC subsequently treated with teat sealant alone (♦) or anti-
biotic plus teat sealant (■) at drying-off across different stages of lactation.
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with antibiotic and leaving 2 quarters untreated, to 
investigate the potential that reducing prophylactic an-
timicrobial treatment at dry-off results in increased use 
of therapeutic antimicrobials. However, those authors 
found that antibiotic use related to mastitis was re-
duced by 85% in quarters treated only therapeutically.
Most studies that have investigated the use of antibi-
otic treatment at drying off are limited to early (Golder 
et al., 2016) or mid subsequent lactation (Sampimon 
et al., 2009; Bradley et al., 2010; Cameron et al., 2014; 
Wittek et al., 2018) only. Yet results from this study 
show that cows treated with antibiotic plus teat seal-
Figure 2. The proportion of cow lactations with an SCC reading >200,000 cells/mL (shaded area) across days in milk when treated with 
internal teat sealant alone (ITS) or antibiotic plus teat sealant (AB+ITS), or when treated with AB+ITS because of a high SCC record in the 
previous lactation (HighSCC).
Table 4. Least squares means (SE in parentheses) of test-day, mean, minimum, and maximum SCS within 
the first 3 records (early), up to 120 DIM (mid), and across lactation (full) for cows that did not have bacteria 
present in their foremilk at dry-off1
Period and  
treatment
SCS
Test-day Mean Minimum Maximum
Early     
 ITS 4.59 (0.051)A 4.60 (0.049)A 4.44 (0.045)A 4.77 (0.061)A
 AB+ITS 4.49 (0.051)B 4.51 (0.049)B 4.35 (0.045)B 4.66 (0.062)B
 HighSCC 4.59 (0.047)A 4.61 (0.045)A 4.44 (0.042)A 4.80 (0.057)A
Mid     
 ITS 4.46 (0.033)A 4.47 (0.040)A 4.02 (0.038)A 5.11 (0.072)A
 AB+ITS 4.38 (0.034)B 4.37 (0.041)B 3.96 (0.040)A 4.90 (0.074)B
 HighSCC 4.37 (0.031)B 4.46 (0.038)A 4.01 (0.036)A 5.11 (0.067)A
Full     
 ITS 4.59 (0.031)A 4.61 (0.035)A 3.96 (0.035)A 5.39 (0.067)A
 AB+ITS 4.51 (0.032)B 4.53 (0.036)B 3.94 (0.036)A 5.19 (0.068)B
 HighSCC 4.59 (0.029)A 4.59 (0.033)A 3.96 (0.033)A 5.48 (0.062)A
A,BMeans with different superscripts within a column and time period differed significantly at P < 0.05.
1LowSCC cows did not exceed 200,000 cells/mL or present with clinical mastitis in the previous lactation; 
HighSCC cows exceeded 200,000 cells/mL at least once or presented with clinical mastitis in previous lacta-
tion. LowSCC cows were treated with teat sealant alone (ITS) or with antibiotic plus teat sealant (AB+ITS); 
HighSCC cows were treated with AB+ITS.
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ant at dry-off had lower SCS throughout lactation than 
cows treated with teat sealant only. The most frequent 
pathogen isolated from the quarters of cows in the pres-
ent study was Staph. aureus (Table 2), a contagious 
pathogen that is shed cyclically and therefore difficult 
to detect using the timed quarter sampling procedure 
outlined in this study. Nonetheless, Staph. aureus is 
known to persist into lactation (Roberson et al., 1994) 
and was detected across lactation in the quarters of 
cows in all treatment groups. Herds with contagious 
pathogens such as Staph. aureus present also benefit 
indirectly from antibiotic treatment through reduced 
exposure of other animals or quarters of the same 
animal to the pathogen (Barkema et al., 2006). In the 
present study, however, all cows—whether treated with 
or without antibiotic—were managed together. Further 
work is required to uncover the mechanism by which 
antibiotic dry-cow therapy protects treated animals 
late into lactation.
Selective Dry-Cow Therapy and Herd-Level SCC
Results from this study showed that prophylactic 
antibiotic treatment at dry-off does reduce SCC across 
the subsequent lactation and reduces the likelihood of 
having high SCC up to mid-lactation. However, the 
SCC and infection rate (as assumed from the incidence 
of high SCC) of the herds that operated selective dry-
cow therapy in the present study were not problematic; 
the back-transformed SCC of LowSCC cows treated 
with ITS alone or treated with AB+ITS were 41,523 
and 34,001 cells/mL, respectively (Table 3; Table 5). 
The unadjusted, untransformed mean SCC across lac-
tation of the ITS and AB+ITS cows were 80,990 and 
60,483 cells/mL, respectively. Additionally, the results 
of the current study show that the proportion of cows 
with SCC that exceeded 200,000 cells/mL at the end 
of lactation was similar for LowSCC cows treated with 
ITS alone and LowSCC cows treated with AB+ITS, 
whereas a higher proportion of HighSCC cows had SCC 
that exceeded 200,000 cells/mL at the end of lacta-
tion (Figure 2). Bulk tank SCC readings from all herds 
remained below 200,000 cells/mL throughout the ma-
jority of the study (Figure 3). Because of the seasonal 
nature of dairy production on the majority of Irish 
dairy herds, SCC trends follow a seasonal pattern, with 
higher SCC found at the start of the year, coinciding 
with calving, early lactation, and indoor housing, and 
again at the end of the year, coinciding with dry-off, 
low milk yields, and indoor housing (McParland et al., 
2013; O’Connell et al., 2015). The bulk tank arithme-
tic mean SCC of research herds involved in this study 
followed this expected seasonal pattern and exceeded 
200,000 cells/mL only at initiation of lactation and dry-
off (Figure 3).
Milk Production
Despite the observed reduction in SCS associated 
with antibiotic treatment and the known negative as-
sociation between SCC and milk yield (Deluyker et 
al., 1993), cows treated with AB+ITS produced 0.67 
kg milk less per day (2.7% of daily yield) compared 
with cows treated with ITS alone in the present study 
(Table 1). Borm et al. (2006) found no difference in the 
milk yield of heifers within the first 200 DIM, whether 
treated with antibiotic and external teat sealant or 
external teat sealant only. However, they did report a 
significant herd × treatment interaction, whereby heif-
ers treated with teat sealant had higher milk yield than 
Table 5. Least squares means of test-day SCS (back transformed SCC in parentheses) within the first 3 
records (early), up to 120 DIM (mid), and across lactation (full) when only cows that had not exceeded 200,000 
cells/mL (SCC200), 150,000 cells/mL (SCC150) or 100,000 cells/mL (SCC100) in the previous lactation were 
included1
Period and  
treatment SCC200 SCC150 SCC100
Early    
 ITS 4.639 (43,530)A 4.637 (43,330)A 4.637 (43,380)A
 AB+ITS 4.546 (35,155)B 4.519 (33,006)B 4.501 (31,658)B
Mid    
 ITS 4.488 (30,746)A 4.486 (30,626)A 4.501 (31,709)A
 AB+ITS 4.384 (24,232)B 4.375 (23,718)B 4.353 (22,562)B
Full    
 ITS 4.618 (41,523)A 4.588 (38,743)A 4.603 (40,104)A
 AB+ITS 4.532 (34,001)B 4.505 (31,981)B 4.491 (31,002)B
A,BMeans with different superscripts within a column and time period denote statistical significance at P < 
0.05.
1Cows were treated with teat sealant alone (ITS) or with antibiotic plus teat sealant (AB+ITS). 
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those treated with antibiotic in only 5 of the 9 herds 
enrolled in the study, corroborating results from this 
study. However, the pathogens involved, as well as the 
timing of IMI, differ between heifers and older cows 
(Pyörälä and Taponen, 2009). Vasquez et al. (2018) 
documented a numerically higher milk yield (P = 0.20) 
across the first 26 DIM in cows treated with teat seal-
ant only compared with cows treated with antibiotic 
and teat sealant. Differences in milk yield were only 
detected later in lactation in the present study (Table 
1). In contrast, Wittek et al. (2018) reported that 
cows who received antibiotics at drying-off yielded 91 
kg more milk than untreated cows in the subsequent 
lactation. However, Wittek et al. (2018) did not report 
on the use of teat sealants in their study population, 
although the use of teat sealants in their population 
was expected to be limited. Differences in the effect of 
antibiotic treatment on subsequent milk yield across 
studies may be influenced by the underlying pathogens 
that the antibiotic was treating.
Animal Identification for Treatment Allocation
Milk test-day SCC records and recorded mastitis 
incidences are useful for identifying animals for dry-
cow treatment, as first reported by Vasquez et al. 
(2018). Although the present study demonstrated no 
difference in the test-day SCS of LowSCC cows treated 
with teat sealant only and HighSCC cows (cows with 
a high SCC or an incidence of mastitis in the previous 
lactation; Table 3), bacteria were identified at dry-off 
(after animals were assigned treatment) in the quarters 
of 28% of HighSCC cow lactations compared with 12% 
of LowSCC cow lactations.
Using milk recording data for use in selective dry-
cow therapy adds another dimension (at no additional 
charge) to the benefits of routine milk recording. In 
Ireland, milk recording participation remains low, 
with less than 50% of Irish dairy cows participating 
in milk recording in 2016. Because the cost saving 
from reduced antibiotic purchase could form a large 
portion of the cost of milk recording (approximately 
25% if milk recording 8 times per lactation), this new 
use of standard milk recording data further improves 
its attractiveness. Weekly milk recording data were 
available in the present study, but this is not likely 
to be feasible in commercial herds, with the exception 
of robotic milking herds. Further work is required to 
identify the optimal number and timing of test-days to 
best identify low-SCC candidates. The cut-off for test-
day results included in the categorization of cows as 
eligible for the present experiment was 4 to 6 wk before 
dry-off because of the increased SCC observed in low-
yielding cows as they approach dry-off (Auldist et al., 
1995). It has been suggested to use at least one record 
within 90 d of drying off to identify cows more likely 
to contract mastitis in the periparturient period (Green 
et al., 2007). Gohary and McDougall (2018) found that 
Figure 3. Bulk tank arithmetic SCC (×1,000 cells/mL) of the 3 research herds for each month of the year across the 3 yr of the study. 
Individual herds are distinguished by unique markers: Moorepark (○), Curtins (Δ), Clonakilty (■); herd years are distinguished by unique line 
style: 2015 (dotted line), 2016 (dashed line), 2017 (solid line).
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a single herd test in late lactation was as useful as 
multiple tests across the lactation as a predictor of IMI 
at drying-off.
An SCC threshold of 200,000 cells/mL is commonly 
used to differentiate between high- and low-SCC ani-
mals (Schukken et al., 2003) and was used in the pres-
ent study to indicate the potential for clinical mastitis 
and IMI. A high SCC threshold, rather than reported 
cases of clinical mastitis, was used in the present study 
because (1) weekly records of SCC were available for 
all animals, and (2) the research herds operated a 
mastitis detection protocol that used (in conjunction 
with on-farm symptom detection) weekly SCC records 
to identify and quarter sample high-SCC cows to de-
termine the need for treatment and the appropriate 
treatment to be used. This early-warning system likely 
reduces the incidence of clinical mastitis below what 
might otherwise be expected. Recently, a document 
produced by the Royal Dutch Veterinary Association 
in the Netherlands to guide the use of antimicrobials 
at dry-off (KNMvD, 2014; summarized by Vanhoudt et 
al., 2018) recommended treatment of primiparous and 
multiparous cows with antimicrobials if SCC exceeded 
150,000 and 50,000 cells/mL, respectively, in the last 
milk recording (within 6 wk of drying off). Ruegg (2016) 
developed a decision tree for selective dry-cow therapy 
based on both herd- and cow-level criteria. To apply 
a selective dry-cow therapy, the herd-level bulk SCC 
has to be <250,000 cells/mL and both monthly cow 
SCC tests and clinical mastitis records are required. 
The cow-level criteria are that SCC has to be <200,000 
cells/mL, no clinical case of mastitis in the last 90 d of 
lactation, and all quarters present with a CMT of <2.
Cows treated with ITS alone had higher SCS than 
cows treated with AB+ITS when the SCC threshold 
for inclusion in the LowSCC group was decreased to 
150,000 or 100,000 cells/mL. However, with the lower 
SCC thresholds, the number of cows included LowSCC, 
and thus available for ITS alone treatment, was de-
creased; therefore, the higher threshold of 200,000 cells/
mL would result in less use of antimicrobials in the herd 
with little effect on the SCC of the herd (Table 5).
CONCLUSIONS
Milk recording data and recording of clinical cow mas-
titis cases are required to identify candidates suitable to 
receive antibiotic-free teat sealant during dry-off. In the 
present study, dry-cow therapy using teat sealant alone 
compared with antibiotic plus teat sealant resulted in 
higher SCC in the subsequent lactation; however, this 
increase in SCC was not large, indicating the potential 
for use of teat seal alone in low-SCC cows in herds 
with good mastitis control programs. This experiment 
should be replicated on commercial dairy farms.
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